CL
Clariant AG
CLZNF · OTC
$10.20 +0.00% (+$0.00)
Market Cap CHF 2.73B
P/E Ratio -
Div. Yield 5.24%
ROE 3.63%
Bulios Fair Price
$12.39
21.5% upside
Current Price
$10.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CLZNF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
88 /100
Cheap P/S 0.70x
P/B 1.35x
P/FCF 11.65x
Growth
8 /100
Declining FCF growth 6.89%
Book val. growth 4.72%
Rev. growth 9.00%
Profitability
57 /100
Moderate Net margin 1.92%
Op. margin 10.17%
FCF margin 5.98%
Quality
11 /100
Poor ROE 3.63%
ROA 1.28%
Asset turnover 0.67x
Debt
54 /100
Moderate Current ratio 1.64x
Int. coverage 1.19x
Net debt/EBITDA 2.70x
Stability
32 /100
Unstable Rev. volatility 6.01%
EPS volatility 168.78%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CLZNF
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Conrad Keijzer
Employees
10,281
Headquarters
Muttenz
Upcoming events
23 FEB
Earnings
Upcoming earnings report